The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.
Open accessAbstract
BACKGROUND: Reactive oxygen species may mediate tissue injury in inflammatory bowel disease. Aminosalicylates have antioxidant activity and the antioxidants, superoxide dismutase and allopurinol, are of reported benefit in inflammatory bowel disease. AIM: To develop a convenient technique for testing the antioxidant potential of standard and novel therapeutic agents for use in inflammatory bowel disease. METHODS: Amplified chemiluminescence was used to measure reactive oxygen species production by colonic biopsy specimens from rats with acetic acid induced colitis and to assess the in vitro effect of conventional antioxidants, standard therapies and proposed novel therapies for inflammatory bowel disease. RESULTS: The model was validated by demonstrating that the profile of effects on chemiluminescence of acetic acid induced colitis biopsy specimens given by conventional antioxidants (sodium azide, catalase, copper-zinc superoxide dismutase, dimethyl sulphoxide, N-acetylcysteine and ascorbate) and standard therapies (5-aminosalicylate and hydrocortisone) resembled that previously reported using biopsy specimens from ulcerative colitis. Human recombinant manganese superoxide dismutase did not alter chemiluminescence. Two novel compounds, LY231617 (10 mM) and amflutizole (20 mM), reduced chemiluminescence by 98% (n = 5, p = 0.009) and 88% (n = 5, p = 0.03), respectively. CONCLUSIONS: The similarity of the chemiluminescence responses of colonic biopsy specimens from acetic acid induced colitis and ulcerative colitis to a range of conventional antioxidants and standard treatments suggests that this model is a useful method for testing the antioxidant potential of new therapies for inflammatory bowel disease. The antioxidant actions of dimethyl sulphoxide, ascorbate, and the novel compounds, amflutizole and LY231617 in this model suggest that these agents merit further assessment in the treatment of inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Cited by
Intestinal redox biology and oxidative stress
Circu, M. L., & Aw, T. Y. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.03.014 · Cited by 324
Mice with combined disruption of Gpx1 and Gpx2 genes have colitis
Esworthy, R. S., Aranda, R., Martín, M. G., Doroshow, J. H., Binder, S. W., & Chu, F.-F. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.3.g848 · Cited by 300
Abdel-Daim, M. M., Farouk, S. M., Madkour, F. F., & Azab, S. S. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2014.998368 · Cited by 164
Metadata
- Authors
- Millar, A. D., Rampton, D. S., Chander, C. L., Claxson, A. W., Blades, S., Coumbe, A., Panetta, J., Morris, C. J., & Blake, D. R.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1996-09
- Volume
- 39
- Issue
- 3
- Pages
- 407-415
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2147931681
- Cited by
- 291
- References
- 1
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. https://app.cochat.ai/papers/10.1136/gut.39.3.407
- The paper
- Millar, A. D., Rampton, D. S., Chander, C. L., Claxson, A. W., Blades, S., Coumbe, A., Panetta, J., Morris, C. J., & Blake, D. R. (1996). Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. https://doi.org/10.1136/gut.39.3.407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.